** Shares of healthcare-based software co Schrodinger
SDGR.O fall 13.1% to $27.26 premarket
** Q4 revenue of $74.10 mln misses Wall Street view of $79
mln - LSEG data
** Quarterly net loss increases to $30.70 mln, compared to a
loss of $27.2 mln in the fourth quarter of 2022
** Co also files for mixed shelf offering; size not
disclosed - SEC filing
** At least four brokerages slash price target on the stock
post results
** Seven of ten brokerages rate the stock "buy" or higher,
three "hold"; their median PT is $38
** Up to Wednesday's close, stock had fallen 12.4% YTD;
compared with ~92% increase in 2023
(Reporting by Khushi Singh in Bengaluru)
((Khushi.Singh@thomsonreuters.com;))